{
    "title": "AstraZeneca starts trial of COVID-19 antibody treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8661221/AstraZeneca-starts-trial-COVID-19-antibody-treatment.html",
    "date": "2020-08-25",
    "keywords": [
        "covid19",
        "astrazeneca",
        "treatment",
        "pushkala",
        "aripaka",
        "aakash",
        "vaccine",
        "combination",
        "development",
        "use",
        "president",
        "b",
        "aug",
        "drugmaker",
        "cocktail",
        "prevention",
        "progress",
        "disease",
        "coronavirus",
        "firm",
        "race",
        "study",
        "mabs",
        "earlystage",
        "trial",
        "azd7442",
        "medicine",
        "midtolatestage",
        "trading",
        "virus",
        "approach",
        "regeneron",
        "eli",
        "roche",
        "body",
        "infection",
        "laboratory",
        "anthony",
        "fauci",
        "bet",
        "june",
        "funding",
        "government",
        "halflife",
        "extension",
        "technology",
        "potential",
        "effectiveness",
        "durability",
        "addition",
        "likelihood",
        "resistance",
        "executive",
        "vice",
        "pangalos",
        "heart",
        "fight",
        "sunday",
        "weekend",
        "administration",
        "approval",
        "jagadeesh",
        "babu",
        "bengaluru",
        "editing",
        "graham"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}